The late disease onset and progressive phenotypes make the PCDHA9 mutant an ALS-relevant physiological system to explore disease mechanisms including the early onset of ALS, and to test potential therapeutics. Here, PCDHA9 is linked to amyotrophic lateral sclerosis.